Company Overview - Coeptis Therapeutics Holdings, Inc. is a next-generation technology and biopharmaceutical company focused on developing innovative cell therapy platforms for cancer, autoimmune, and infectious diseases [3][4] - The company has a therapeutic portfolio that includes assets licensed from Deverra Therapeutics, featuring an allogeneic cellular immunotherapy platform and DVX201, a clinical-stage natural killer cell therapy technology [4] - Coeptis is also developing a universal, multi-antigen CAR technology licensed from the University of Pittsburgh, alongside GEAR cell therapy and companion diagnostic platforms in collaboration with VyGen-Bio and the Karolinska Institute [4] Recent Developments - Coeptis has filed a registration statement on Form S-4 with the SEC related to a proposed merger agreement with Z Squared Inc. [1][2] - The Form S-4 includes a preliminary proxy statement/prospectus regarding the proposed transaction, which has not yet become effective [2] Technology Division - Coeptis has established a Technology Division aimed at enhancing operational capabilities through advanced technologies, including AI-powered marketing software and robotic process automation tools acquired from NexGenAI Solutions Group [5] Z Squared Overview - Z Squared Inc. is focused on digital asset compute mining, primarily generating Dogecoin (DOGE) and other digital assets like Litecoin, with a market cap of $20 billion [7]

Core Viewpoint - Coeptis Therapeutics Holdings, Inc. and Z Squared Inc. have entered into a definitive merger agreement, resulting in Z Squared becoming a wholly-owned subsidiary of Coeptis, with a focus on Dogecoin mining and a planned spin-out of Coeptis' biopharmaceutical operations [1][5][10] Company Overview - Coeptis Therapeutics is a biopharmaceutical and technology company that develops innovative cell therapy platforms for cancer, autoimmune, and infectious diseases [1][6] - Z Squared Inc. specializes in digital asset mining, primarily focusing on Dogecoin, which has a market capitalization exceeding $20 billion [2][10] Merger Details - The merger will involve a wholly-owned subsidiary of Coeptis merging with Z Squared, with Z Squared shareholders receiving equity in Coeptis in exchange for 9,000 U.S.-based Dogecoin mining machines [1] - The transaction is expected to close in the third quarter of 2025, pending regulatory approvals and shareholder consent [1] Leadership Changes - Post-merger, Z Squared executives will lead the combined entity, with David Halabu as CEO and Michelle Burke as COO [3][4] - Current Coeptis CEO Dave Mehalick will exit the Board of Directors upon closing [3] Strategic Focus - The combined company aims to create the largest publicly-traded entity in the U.S. focused on Dogecoin mining, targeting both retail and institutional investors [5] - Coeptis plans to maintain its biopharmaceutical operations separately after the merger, allowing continued involvement in both sectors [5]

Core Insights - COEPTIS, Inc. has established a new co-working technology hub in India in partnership with NexGenAI Solutions Group and Ishvara Tech Consulting LLP, aimed at enhancing access to AI, blockchain, biopharma, and defense technologies [1][2][3] Company Overview - COEPTIS is a pioneering technology firm focused on innovative biotechnology solutions, with a strong emphasis on developing advanced cell therapy platforms for various diseases [8][9] - The company has recently expanded its technology division, which includes AI-powered marketing software and robotic process automation tools acquired from NexGenAI Solutions Group [10] Strategic Initiatives - The new India hub will focus on several key initiatives, including Research & Development, AI marketing strategy execution, crypto strategy execution, and advanced blockchain applications [4] - The hub is designed to support the development and integration of the NXG Token across digital platforms, enhancing the blockchain ecosystem and exploring monetization strategies rooted in data analytics and automation [4] Recent Achievements - COEPTIS has recently acquired the NexGenAI Affiliates Network platform and signed contracts valued at $2.3 million, including a $600,000 deal with NUBURU, Inc., indicating strong demand for its AI-powered marketing software [3][4] Infrastructure and Facilities - The India hub features a 60-seat capacity, expandable to 100, with modern amenities including executive cabins, conference rooms, and high-speed fiber optic internet [6]